Sanofi Proceeds From Sales Of Investments Accounted For Using Equity Method
Sanofi (SNYNF) reported Proceeds From Sales Of Investments Accounted For Using Equity Method of EUR 0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-02-24.
Discontinued › Cash Flow
ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod · last filed 2023-02-24
| Period end | Proceeds From Sales Of Investments Accounted For Using Equity Method 6 month | Proceeds From Sales Of Investments Accounted For Using Equity Method 12 month |
|---|---|---|
| 2022-12-31 | 0.00 EUR 20-F · filed 2023-02-24 | |
| 2021-12-31 | 0.00 EUR 20-F · filed 2023-02-24 | |
| 2021-06-30 | 0.00 EUR 6-K · filed 2021-07-29 | |
| 2020-12-31 | 10.37B EUR 20-F · filed 2023-02-24 | |
| 2020-06-30 | 10.51B EUR 6-K · filed 2021-07-29 | |
| 2019-12-31 | 0.00 EUR 20-F · filed 2022-02-23 | |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-04 |